Adaptive Industry Symposium
Measurable Residual Disease (MRD) in Multiple Myeloma: A Real-World Experience Perspective
Saturday, May 8, 2021 – 20:00-21:00 CEST
Joaquin Martinez-Lopez
Madrid, Spain
Karthik Ramasamy
Oxford, UK
Rafael Fonseca
Scottsdale, AZ – USA
AGENDA:
| 20:00-20:15 | Monitoring Measurable Residual Disease (MRD) for the Management of Multiple Myeloma Patients (MM): Real-World Evidence Joaquin Martinez-Lopez, Madrid, Spain |
| 20:15-20:30 | Monitoring MRD in Clinical Practice in a Dynamic Multiple Myeloma (MM) Treatment Landscape – Introducing the Delphi Initiative Karthik Ramasamy, Oxford, UK |
| 20:30-20:45 | Managing Multiple Myeloma (MM) in Real-World Practice: Clinical Actionability of MRD Rafael Fonseca, Scottsdale, AZ – USA |
| 20:45-21:00 | Panel Discussion / Q&A |